Traynor Capital Management, Inc. Renalytix PLC Transaction History

Traynor Capital Management, Inc.

  • $1.6 Billion
  • Q3 2024

A detailed history of Traynor Capital Management, Inc. transactions in Renalytix PLC stock. As of the latest transaction made, Traynor Capital Management, Inc. holds 61,750 shares of RNLX stock, worth $9,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,750
Previous 60,000 2.92%
Holding current value
$9,262
Previous $13,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
BUY
$0.21 - $0.45 $367 - $787
1,750 Added 2.92%
61,750 $12,000
Q2 2024

Jul 24, 2024
BUY
$0.23 - $0.93 $13,800 - $55,800
60,000 New
60,000 $13,000

Others Institutions Holding RNLX

# of Institutions
31
Shares Held
3.78M
Call Options Held
0
Put Options Held
0
View Full List

About Renalytix plc

RNLX Quotes by TradingView
  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Traynor Capital Management, Inc. Portfolio

Follow Traynor Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Traynor Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email